Advancing pathology in fight against cancer.
We are a technology company focused on AI-powered decision support algorithms, workflow solutions, and telepathology platforms. Our story is one of resilience, innovation, and commitment to making a positive impact on peoples lives.
Virasoft’s journey began in 2017, founded by two childhood friends and young engineers who shared a deep sense of purpose. Growing up in an area profoundly impacted by the 1986 Chernobyl nuclear disaster, they witnessed firsthand the devastating rise in cancer cases within their hometowns. This experience ignited their passion and determination to make a difference in pathology and cancer care.
Our mission has been clear from the beginning: leveraging technology to improve cancer diagnosis and treatment.
Today, Virasoft operates from Istanbul and New York, combining clinical expertise, innovation, and advanced technology to support pathology laboratories worldwide. We are committed to improving pathology workflows, enabling seamless processes, and increasing diagnostic accuracy through intelligent, integrated solutions.
Virasoft solutions now support more than 950,000 cases annually across 20+ institutions, helping hundreds of pathologists streamline workflows, collaborate more effectively, and make faster, more confident diagnostic decisions.